SEI Investments’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
SEI Investments's RXRX Position: Q3 2026 in Review
SEI Investments increased its Recursion Pharmaceuticals (RXRX) stake by 142% in Q3 2026, buying an estimated $243K and bringing the position to 122,185 shares worth $505K. The position accounts for ﹤0.01% of the portfolio, ranked #2637.
SEI Investments first reported a position in RXRX in Q3 2024 and has held it in 9 quarters since. 178 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- SEI Investments held 122,185 shares of Recursion Pharmaceuticals worth $505K as of Q3 2026.
- SEI Investments bought 71,737 Recursion Pharmaceuticals shares in Q3 2026, an estimated $243K.
- Recursion Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2637 holding.
- SEI Investments first reported a position in Recursion Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
- 178 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.